Table 1.

Homolog peptides identified in human exome by in silico screening

Sequences tested for cross-reactivity to RMFPNAPYL Epitope nameSequences found in exome (<1 μM Kd)Source proteinHLA-A2 binding (KD prediction)
X(LMV)FPNAPY(LVI) WT1-RMF RMFPNAPYL WT1 7 nM 
X(LMV)FPNAPY(LVI)
And substitute any other position with any conserved amino acid 
ABHD3-9-mer SLYPSAPFL Phospholipase ABHD3 7 nM 
Same as previous row but with 10 residues instead ABHD3-10-mer SLYPSAPFLA Phospholipase ABHD3 14 nM 
 AMFR EMFPQVPYHL Autocrine motility factor receptor 148 nM 
Identified previously (Ref 20) TSTP1-10-mer RLFPNAKFLL Tyrosyl protein sulfotransferase 1 27 nM 
Sequences tested for cross-reactivity to RMFPNAPYL Epitope nameSequences found in exome (<1 μM Kd)Source proteinHLA-A2 binding (KD prediction)
X(LMV)FPNAPY(LVI) WT1-RMF RMFPNAPYL WT1 7 nM 
X(LMV)FPNAPY(LVI)
And substitute any other position with any conserved amino acid 
ABHD3-9-mer SLYPSAPFL Phospholipase ABHD3 7 nM 
Same as previous row but with 10 residues instead ABHD3-10-mer SLYPSAPFLA Phospholipase ABHD3 14 nM 
 AMFR EMFPQVPYHL Autocrine motility factor receptor 148 nM 
Identified previously (Ref 20) TSTP1-10-mer RLFPNAKFLL Tyrosyl protein sulfotransferase 1 27 nM 

Potential off-target sequences were identified using ScanProsite (Expasy) to search the human exome (UniProtKB/Swiss-Prot) for homologous 9 amino acid peptides that had predicted affinity to HLA-A∗02:01 (HLA-A2) of <500 nM using NetMHCPan.

The rules used to identify potential off-target sequences are as follows: position no. 1 could be any amino acid “X”; position no. 2 and no. 9 could be any canonical anchor (LMV) and (LVI). Position no.3 to no.8 could be replaced with any conserved residues, shown hereafter, at their respective positions in RMFPNAPYL: F→Y = W; P→P; N→S = T = Q; A→V = I = G; Y→F = W. Additional homologous 10-mers were also included. TSTP1 was identified in a previous study.20 

Close Modal

or Create an Account

Close Modal
Close Modal